|Genetic variation in IL28B and spontaneous clearance of hepatitis C virus|
DL Thomas, CL Thio, MP Martin, Y Qi, D Ge, C O’hUigin, J Kidd, K Kidd, ...
Nature 461 (7265), 798, 2009
|HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection|
SI Khakoo, CL Thio, MP Martin, CR Brooks, X Gao, J Astemborski, ...
Science 305 (5685), 872-874, 2004
|HIV-1 adaptation to NK-cell-mediated immune pressure|
G Alter, D Heckerman, A Schneidewind, L Fadda, CM Kadie, JM Carlson, ...
Nature 476 (7358), 96, 2011
|Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans|
SI Khakoo, R Rajalingam, BP Shum, K Weidenbach, L Flodin, DG Muir, ...
Immunity 12 (6), 687-698, 2000
|KIR and disease: a model system or system of models?|
SI Khakoo, M Carrington
Immunological reviews 214 (1), 186-201, 2006
|Consistent beneficial effects of killer cell immunoglobulin‐like receptor 2DL3 and group 1 human leukocyte antigen‐C following exposure to hepatitis C virus|
S Knapp, U Warshow, D Hegazy, L Brackenbury, IN Guha, A Fowell, ...
Hepatology 51 (4), 1168-1175, 2010
|Activation of natural killer cells during acute infection with hepatitis C virus|
B Amadei, S Urbani, A Cazaly, P Fisicaro, A Zerbini, P Ahmed, G Missale, ...
Gastroenterology 138 (4), 1536-1545, 2010
|Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts|
P Duggal, CL Thio, GL Wojcik, JJ Goedert, A Mangia, R Latanich, AY Kim, ...
Annals of internal medicine 158 (4), 235-245, 2013
|Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions|
S Khakoo, P Glue, L Grellier, B Wells, A Bell, C Dash, I Murray‐Lyon, ...
British journal of clinical pharmacology 46 (6), 563-570, 1998
|Peptide antagonism as a mechanism for NK cell activation|
L Fadda, G Borhis, P Ahmed, K Cheent, SV Pageon, A Cazaly, ...
Proceedings of the National Academy of Sciences 107 (22), 10160-10165, 2010
|MAIT cells are activated during human viral infections|
B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ...
Nature communications 7, 11653, 2016
|Natural killer cells: integrating diversity with function|
K Cheent, SI Khakoo
Immunology 126 (4), 449-457, 2009
|Hanging in the balance|
AP Williams, AR Bateman, SI Khakoo
Molecular interventions 5 (4), 226, 2005
|KIR/HLA interactions and pathogen immunity|
KM Jamil, SI Khakoo
BioMed Research International 2011, 2011
|Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses|
S Pelletier, C Drouin, N Bédard, SI Khakoo, J Bruneau, NH Shoukry
Journal of hepatology 53 (5), 805-816, 2010
|Conservation and variation in human and common chimpanzee CD94 and NKG2 genes|
BP Shum, LR Flodin, DG Muir, R Rajalingam, SI Khakoo, S Cleland, ...
The Journal of Immunology 168 (1), 240-252, 2002
|Histological assessment of the Sydney classification of endoscopic gastritis.|
SI Khakoo, AJ Lobo, NA Shepherd, SP Wilkinson
Gut 35 (9), 1172-1175, 1994
|Natural killer cells and hepatitis C: action and reaction|
K Cheent, SI Khakoo
Gut 60 (2), 268-278, 2011
|A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection|
S Knapp, U Warshow, KMA Ho, D Hegazy, AM Little, A Fowell, ...
Gastroenterology 141 (1), 320-325. e2, 2011
|Understanding the host genetics of chronic hepatitis B and C|
M Thursz, L Yee, S Khakoo
Seminars in liver disease 31 (02), 115-127, 2011